Newron Pharmaceuticals S.p.A. (NWPHF)
OTCMKTS · Delayed Price · Currency is USD
12.00
+0.60 (5.26%)
May 15, 2024, 9:30 AM EDT
Newron Pharmaceuticals Market Cap
Newron Pharmaceuticals has a market cap or net worth of $352.53 million as of October 7, 2025. Its market cap has increased by 87.56% in one year.
Market Cap
352.53M
Enterprise Value
363.50M
Revenue
70.32M
Ranking
n/a
PE Ratio
11.85
Stock Price
$12.00
Market Cap Chart
Since December 12, 2006, Newron Pharmaceuticals's market cap has increased from 257.00M to 352.53M, an increase of 37.17%. That is a compound annual growth rate of 1.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 353.81M | 84.27% |
| Dec 30, 2024 | 192.01M | 83.04% |
| Dec 29, 2023 | 104.90M | 250.69% |
| Dec 30, 2022 | 29.91M | -5.41% |
| Dec 30, 2021 | 31.62M | -27.17% |
| Dec 30, 2020 | 43.42M | -62.90% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 798.20M |
| Elite Pharmaceuticals | 686.89M |
| Glass House Brands | 644.95M |
| Northwest Biotherapeutics | 382.92M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 326.79M |
| American Oncology Network | 281.53M |
| Silence Therapeutics | 236.17M |